For the Inventor, By the Inventor

Enter assignee name

Adocia

USPTO Granted Patents = 43

% Expired Patents = 32.6

EPO Patents = 24

Trademarks = 3

Forward Citations = 86

Loading Chart...

Loading Chart...

25 inventors (with patents filed for the assignee):

Olivier Soula (24 out of 33 patents)

Richard Charvet (20 out of 20 patents)

Alexandre Geissler (13 out of 13 patents)

4. Remi Soula (13 out of 13 patents)

5. You-Ping Chan (9 out of 41 patents)

6. Gerard Soula (9 out of 61 patents)

7. Romain Noel (8 out of 8 patents)

8. Nicolas Laurent (8 out of 8 patents)

9. Gérard Soula (6 out of 14 patents)

10. Bertrand Alluis (5 out of 5 patents)

11. David Duracher (5 out of 5 patents)

12. Grégory Meiffren (4 out of 4 patents)

13. Walter Roger (3 out of 3 patents)

14. Emmanuel Dauty (3 out of 3 patents)

15. Ségolène Laage (3 out of 3 patents)

Core Competencies:

Insulin Compositions

Hydrogels

Aqueous Solutions

Amylin Analogues

Polysaccharides

Fast-Acting Insulin

Co-Polyamino Acids

Glucagon

Viscosity Reduction

Anionic Compounds

Protein Complexes

Substituted Oligosaccharides

43 patents: Sort by Forward Citations

1. 12544349 - COMPOSITIONS COMPRISING PEMVIDUTIDE AND AN ACYLATED AMINO ACID (2026-02-10),

2. 12421327 - Hydrogels for cell therapy (2025-09-23),

3. 12186373 - Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid (2025-01-07),

4. 11883496 - Injectable pH 7 solution comprising at least one basal insulin having a pI from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals (2024-01-30),

5. 11707507 - Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog, and a co-polyamino acid (2023-07-25),

6. 11633460 - Injectable solution at pH 7 comprising at least one basal insulin wherein the pI is comprised from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals (2023-04-25),

7. 11576952 - Injectable solution at pH 7 comprising at least one basal insulin for which the pI is from 5.8 to 8.5 and a co-polyamino acid bearing carboxylate charges and hydrophobic radicals (2023-02-14),

8. 11324808 - Rapid-acting insulin formulation comprising a substituted anionic compound (2022-05-10),

9. 11191812 - Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid (2021-12-07),

10. 11173109 - Compositions in the form of an injectable aqueous solution comprising amylin, an amylin receptor agonist or an amylin analog and a co-polyamino acid (2021-11-16),

11. 11129877 - Compositions in the form of an injectable aqueous solution comprising amylin, an amylin agonist receptor or an amylin analogue and a co-polyamino acid (2021-09-28),

12. 11065305 - Compositions in the form of an injectable aqueous solution including at least human insulin A21G and a glucagon suppressor with prandial action (2021-07-20),

13. 10987426 - Compositions in the form of an injectable aqueous solution comprising human glucagon and a co-polyamino acid (2021-04-27),

14. 10881716 - Rapid-acting insulin formulation comprising a substituted anionic compound (2021-01-05),

15. 10792335 - Rapid-acting insulin composition comprising a substituted citrate (2020-10-06),

Company Overview

Adocia is a biotechnology company based in Lyon, France, specializing in the development of innovative therapeutic solutions for diabetes and other metabolic diseases. The company focuses on advanced drug delivery systems, particularly hydrogels and injectable solutions, to enhance the efficacy of insulin therapies. Adocia's research encompasses various technology domains, including amylin analogues, basal and rapid-acting insulin formulations, human glucagon, and co-polyamino acids, aiming to improve patient outcomes through novel treatment approaches.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

43 Patents

#9 in Lyon

#542 in France

#16,047 in the World

Adocia

Forward Citations = 86

25 inventors:

Olivier Soula (24 out of 33 patents)

Richard Charvet (20 out of 20 patents)

Alexandre Geissler (13 out of 13 patents)

4. Remi Soula (13 out of 13 patents)

5. You-Ping Chan (9 out of 41 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Adocia. Retrieved from https://idiyas.com/company/adocia

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…